# Bristol-Myers Squibb (BMY) SEC filings: 10-K, 10-Q and 8-K

URL: https://funkfolio.com/stock/BMY/filings

> Bristol-Myers Squibb (BMY) SEC filings from EDGAR: 10-K filed Feb 11, 2026, 10-Q filed Oct 29, 2026, 8-K filed Oct 29, 2026. 89 filings in the last 12 months.

---

## Bristol-Myers Squibb (BMY) SEC filings

Bristol-Myers Squibb's latest annual report is a Form 10-K filed on February 11, 2026 for the period ended December 31, 2025. Its latest quarterly report, a Form 10-Q, was filed on October 29, 2026. Its latest current report, a Form 8-K, was filed on October 29, 2026. EDGAR lists 89 filings for it in the last twelve months.

### Key facts

- **Latest annual report:** 10-K, Feb 11, 2026
- **Latest quarterly report:** 10-Q, Oct 29, 2026
- **Latest 8-K:** 8-K, Oct 29, 2026
- **Filings, last 12 months:** 89
- **Insider forms, last 12 months:** 63 Forms 3, 4 and 5
- **13D and 13G, last 12 months:** 3
- **SEC central index key:** 0000014272

Filings as listed by SEC EDGAR at Nov 18, 2026, 10:24 UTC (re-read at most hourly). Source: [SEC EDGAR filings for CIK 0000014272](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000014272). Every form links to its document on sec.gov. Older filings are in EDGAR's archive; the tables here cover its recent list (at least the last year).

### Annual and quarterly reports

Bristol-Myers Squibb: annual and quarterly reports filed with the SEC

| Form | Filed | Period ended | Document |
| --- | --- | --- | --- |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427226000024/bmy-20260930.htm) | Oct 29, 2026 | Sep 30, 2026 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/bmy-20260630.htm) | Jul 30, 2026 | Jun 30, 2026 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427226000010/bmy-20260331.htm) | Apr 30, 2026 | Mar 31, 2026 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/14272/000001427226000004/bmy-20251231.htm) | Feb 11, 2026 | Dec 31, 2025 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427225000149/bmy-20250930.htm) | Oct 30, 2025 | Sep 30, 2025 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427225000131/bmy-20250630.htm) | Jul 31, 2025 | Jun 30, 2025 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/bmy-20250331.htm) | Apr 24, 2025 | Mar 31, 2025 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/14272/000001427225000039/bmy-20241231.htm) | Feb 12, 2025 | Dec 31, 2024 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427224000147/bmy-20240930.htm) | Oct 31, 2024 | Sep 30, 2024 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427224000123/bmy-20240630.htm) | Jul 26, 2024 | Jun 30, 2024 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427224000096/bmy-20240331.htm) | Apr 25, 2024 | Mar 31, 2024 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/14272/000001427224000044/bmy-20231231.htm) | Feb 13, 2024 | Dec 31, 2023 | Annual report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427223000181/bmy-20230930.htm) | Oct 26, 2023 | Sep 30, 2023 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427223000152/bmy-20230630.htm) | Jul 27, 2023 | Jun 30, 2023 | Quarterly report |
| [10-Q](https://www.sec.gov/Archives/edgar/data/14272/000001427223000104/bmy-20230331.htm) | Apr 27, 2023 | Mar 31, 2023 | Quarterly report |
| [10-K](https://www.sec.gov/Archives/edgar/data/14272/000001427223000046/bmy-20221231.htm) | Feb 14, 2023 | Dec 31, 2022 | Annual report |

The latest 16 of 31 in EDGAR's recent list. Amended reports are marked. The period is the fiscal year or quarter the report covers.

### Current reports (8-K)

Bristol-Myers Squibb: current reports on Form 8-K and the items each reports

| Form | Filed | Event date | What it reports |
| --- | --- | --- | --- |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000001427226000022/bmy-20261029.htm) | Oct 29, 2026 | Oct 29, 2026 | 2.02 Results of Operations and Financial Condition 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000001427226000018/bmy-20260730.htm) | Jul 30, 2026 | Jul 30, 2026 | 2.02 Results of Operations and Financial Condition 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000114036126020036/ef20072750_8k.htm) | May 8, 2026 | May 5, 2026 | 5.07 Submission of Matters to a Vote of Security Holders |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000001427226000008/bmy-20260430.htm) | Apr 30, 2026 | Apr 30, 2026 | 2.02 Results of Operations and Financial Condition 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000001427226000002/bmy-20260205.htm) | Feb 5, 2026 | Feb 5, 2026 | 2.02 Results of Operations and Financial Condition 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000114036126000929/ef20062582_8k.htm) | Jan 12, 2026 | Jan 12, 2026 | 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000114036125042607/ef20059419_8k.htm) | Nov 18, 2025 | Nov 17, 2025 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000114036125041380/ny20057651x6_8k.htm) | Nov 10, 2025 | Oct 31, 2025 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000114036125040066/ef20058056_8k.htm) | Nov 3, 2025 | Nov 3, 2025 | 8.01 Other Events 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000001427225000147/bmy-20251030.htm) | Oct 30, 2025 | Oct 30, 2025 | 2.02 Results of Operations and Financial Condition 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000001427225000129/bmy-20250731.htm) | Jul 31, 2025 | Jul 31, 2025 | 2.02 Results of Operations and Financial Condition 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000114036125027350/ef20052589_8k.htm) | Jul 25, 2025 | Jul 21, 2025 | 5.02 Departure or Election of Directors or Officers; Officer Compensation 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000114036125017742/ef20048602_8k.htm) | May 7, 2025 | May 6, 2025 | 5.07 Submission of Matters to a Vote of Security Holders |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000001427225000089/bmy-20250424.htm) | Apr 24, 2025 | Apr 24, 2025 | 2.02 Results of Operations and Financial Condition 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000114036125005012/ef20043809_8k.htm) | Feb 18, 2025 | Feb 14, 2025 | 5.02 Departure or Election of Directors or Officers; Officer Compensation |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000001427225000037/bmy-20250206.htm) | Feb 6, 2025 | Feb 6, 2025 | 2.02 Results of Operations and Financial Condition 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000114036125000885/ef20041375_8k.htm) | Jan 13, 2025 | Jan 13, 2025 | 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000001427224000145/bmy-20241031.htm) | Oct 31, 2024 | Oct 31, 2024 | 2.02 Results of Operations and Financial Condition 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000001427224000121/bmy-20240726.htm) | Jul 26, 2024 | Jul 26, 2024 | 2.02 Results of Operations and Financial Condition 7.01 Regulation FD Disclosure 9.01 Financial Statements and Exhibits |
| [8-K](https://www.sec.gov/Archives/edgar/data/14272/000114036124030533/ef20031337_8k.htm) | Jun 18, 2024 | Jun 18, 2024 | 5.02 Departure or Election of Directors or Officers; Officer Compensation 9.01 Financial Statements and Exhibits |

The latest 20 of 125 in EDGAR's recent list. Item names are the SEC's own, from Form 8-K (a few long ones shortened). The event date is the date of the earliest event reported.

### Insider forms (3, 4 and 5)

Bristol-Myers Squibb: insider forms 3, 4 and 5 filed per month over the last twelve months

| Month | Forms filed |
| --- | --- |
| Nov 2026 | 5 |
| Oct 2026 | 6 |
| Sep 2026 | 2 |
| Aug 2026 | 3 |
| Jul 2026 | 5 |
| Jun 2026 | 2 |
| May 2026 | 1 |
| Apr 2026 | 7 |
| Mar 2026 | 15 |
| Feb 2026 | 12 |
| Jan 2026 | 5 |
| Dec 2025 | 0 |

Bristol-Myers Squibb: the latest insider forms

| Form | Filed | Transaction date |
| --- | --- | --- |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000165608226000006/xslF345X06/wk-form4_1794000342.xml) | Nov 6, 2026 | Nov 5, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000197571926000006/xslF345X06/wk-form4_1793828962.xml) | Nov 4, 2026 | Nov 3, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000154374726000004/xslF345X06/wk-form4_1793741399.xml) | Nov 3, 2026 | Nov 1, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000191732526000006/xslF345X06/wk-form4_1793741222.xml) | Nov 3, 2026 | Nov 1, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000190876926000006/xslF345X06/wk-form4_1793740736.xml) | Nov 3, 2026 | Nov 1, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000199505826000007/xslF345X06/wk-form4_1791231537.xml) | Oct 5, 2026 | Oct 2, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000126907026000011/xslF345X06/wk-form4_1790972811.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000168827626000010/xslF345X06/wk-form4_1790972748.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000135906726000012/xslF345X06/wk-form4_1790972690.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000141894926000010/xslF345X06/wk-form4_1790972595.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000132313426000024/xslF345X06/wk-form4_1790972525.xml) | Oct 2, 2026 | Sep 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000208017626000006/xslF345X06/wk-form4_1789072637.xml) | Sep 10, 2026 | Sep 9, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000207083926000007/xslF345X06/wk-form4_1788466344.xml) | Sep 3, 2026 | Sep 1, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000201258826000004/xslF345X06/wk-form4_1787775463.xml) | Aug 26, 2026 | Aug 25, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000208017626000004/xslF345X06/wk-form4_1785874216.xml) | Aug 4, 2026 | Aug 1, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000199505826000005/xslF345X06/wk-form4_1785874049.xml) | Aug 4, 2026 | Aug 1, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000126907026000009/xslF345X06/wk-form4_1783023606.xml) | Jul 2, 2026 | Jun 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000168827626000008/xslF345X06/wk-form4_1783023508.xml) | Jul 2, 2026 | Jun 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000135906726000010/xslF345X06/wk-form4_1783023445.xml) | Jul 2, 2026 | Jun 30, 2026 |
| [4](https://www.sec.gov/Archives/edgar/data/14272/000141894926000008/xslF345X06/wk-form4_1783023386.xml) | Jul 2, 2026 | Jun 30, 2026 |

The latest 20 of 669 in EDGAR's recent list. Each form is filed by the insider about their own holding; the trade details are inside the form on sec.gov. Counts include amendments. The current month is counted to date.

### Ownership reports (Schedules 13D and 13G)

Bristol-Myers Squibb: Schedule 13D and 13G beneficial ownership reports

| Form | Filed | Event date |
| --- | --- | --- |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/14272/000009375126000422/xslSCHEDULE_13G_X02/primary_doc.xml) | Aug 7, 2026 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/14272/000210011926000248/xslSCHEDULE_13G_X02/primary_doc.xml) | Apr 29, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000010290926000896/xslSCHEDULE_13G_X02/primary_doc.xml) | Mar 26, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000001961725001051/xslSCHEDULE_13G_X01/primary_doc.xml) | Oct 31, 2025 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/14272/000001961725000397/xslSCHEDULE_13G_X01/primary_doc.xml) | Apr 25, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000157641925000707/xslSCHEDULE_13G_X01/primary_doc.xml) | Apr 17, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036125004784/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 14, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036125004783/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 14, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036125004782/xslSCHEDULE_13G_X01/primary_doc.xml) | Feb 14, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036124046455/ef20038544_sc13ga.htm) | Nov 13, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036124046454/ef20038543_sc13ga.htm) | Nov 13, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036124046453/ef20038542_sc13ga.htm) | Nov 13, 2024 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/14272/000114036124046452/ef20038540_sc13g.htm) | Nov 13, 2024 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/14272/000114036124042895/ef20036681_sc13g.htm) | Oct 4, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000110465924020478/tv0481-bristolmyerssquibbco.htm) | Feb 13, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000108636424003753/us1101221083_012524.txt) | Jan 25, 2024 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/14272/000114036123056127/ef20016011_sc13g.htm) | Dec 4, 2023 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000110465923015507/tv0461-bristolmyerssquibbco.htm) | Feb 9, 2023 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000130655023008279/us1101221083_020723.txt) | Feb 7, 2023 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/14272/000110465922016692/tv0463-bristolmyerssquibbco.htm) | Feb 9, 2022 | — |

The latest 20 of 35 in EDGAR's recent list. Filed by the holder, not the company. EDGAR's list names the form and date; who filed it is in the document.

### Proxy statements

Bristol-Myers Squibb: proxy statements and proxy materials

| Form | Filed | Meeting or period | Document |
| --- | --- | --- | --- |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036126015377/ef20070631_defa14a.htm) | Apr 17, 2026 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036126011110/ef20067096_defa14a.htm) | Mar 25, 2026 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/14272/000001427226000006/bmy-20260325.htm) | Mar 25, 2026 | May 5, 2026 | Definitive proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036125013981/ef20047411_defa14a.htm) | Apr 15, 2025 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036125010440/ef20046114_defa14a.htm) | Mar 26, 2025 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/14272/000001427225000075/bmy-20250326.htm) | Mar 26, 2025 | Dec 31, 2024 | Definitive proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036124020908/ef20027324_defa14a.htm) | Apr 22, 2024 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036124016269/ny20016133x3_defa14a.htm) | Mar 28, 2024 | — | FORM DEFA14A |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/14272/000114036124016251/ny20016133x2_def14a.htm) | Mar 28, 2024 | May 7, 2024 | Definitive proxy statement |
| [PRE 14A](https://www.sec.gov/Archives/edgar/data/14272/000114036124013975/ny20016133x1_pre14a.htm) | Mar 18, 2024 | May 7, 2024 | Preliminary proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036123020613/brhc20052030_defa14a.htm) | Apr 26, 2023 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036123017590/brhc10023253_defa14a.htm) | Apr 10, 2023 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036123013445/ny20006581x2_defa14a.htm) | Mar 23, 2023 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/14272/000114036123013442/ny20006581x1_def14a.htm) | Mar 23, 2023 | — | Definitive proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036122015195/brhc10036529_defa14a.htm) | Apr 20, 2022 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036122010992/ny20002084x2_defa14a.htm) | Mar 24, 2022 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/14272/000114036122010987/ny20002084x1_def14a.htm) | Mar 24, 2022 | May 3, 2022 | Definitive proxy statement |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036121013202/brhc10023253_defa14a.htm) | Apr 19, 2021 | — |  |
| [DEFA14A](https://www.sec.gov/Archives/edgar/data/14272/000114036121010014/nc10020324x3_defa14a.htm) | Mar 25, 2021 | — |  |
| [DEF 14A](https://www.sec.gov/Archives/edgar/data/14272/000114036121010010/nc10020324x2_def14a.htm) | Mar 25, 2021 | May 4, 2021 | Definitive proxy statement |

The latest 20 of 26 in EDGAR's recent list.

**Everything else (118 filings: registrations, prospectuses, Rule 144 notices, correspondence and more)**

Bristol-Myers Squibb: other SEC filings

| Form | Filed | Period | Document |
| --- | --- | --- | --- |
| [144](https://www.sec.gov/Archives/edgar/data/14272/000162828026071514/xsl144X01/primary_doc.xml) | Nov 6, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/14272/000195917326006809/xsl144X01/primary_doc.xml) | Sep 9, 2026 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/14272/000195917326006424/xsl144X01/primary_doc.xml) | Aug 25, 2026 | — | Notice of proposed sale |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427226000016/bmy-20260605.htm) | Jun 5, 2026 | Dec 31, 2025 | FORM 11-K |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427226000015/bmy-20260605.htm) | Jun 5, 2026 | Dec 31, 2025 | FORM 11-K |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427226000014/bmy-20260605.htm) | Jun 5, 2026 | Dec 31, 2025 | FORM 11-K |
| [S-8](https://www.sec.gov/Archives/edgar/data/14272/000114036126020060/ef20072737_s8.htm) | May 8, 2026 | — | Registration statement for employee plans |
| [144](https://www.sec.gov/Archives/edgar/data/14272/000195917326002718/xsl144X01/primary_doc.xml) | Apr 1, 2026 | — | Notice of proposed sale |
| [15-12G](https://www.sec.gov/Archives/edgar/data/14272/000114036126011729/ef20068734_1512g.htm) | Mar 27, 2026 | — |  |
| [ARS](https://www.sec.gov/Archives/edgar/data/14272/000114036126011149/ef20068747_ars.pdf) | Mar 25, 2026 | Dec 31, 2025 |  |
| [CERT](https://www.sec.gov/Archives/edgar/data/14272/000087666125000862/BMYNotes111225.pdf) | Nov 12, 2025 | — | NYSE CERTIFICATION |
| [8-A12B](https://www.sec.gov/Archives/edgar/data/14272/000114036125041407/ny20057651x7_8a12b.htm) | Nov 10, 2025 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/14272/000114036125041159/ny20057651x5_424b5.htm) | Nov 7, 2025 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/14272/000114036125040552/ny20057651x3-x4_fwp.htm) | Nov 5, 2025 | — |  |
| [424B2](https://www.sec.gov/Archives/edgar/data/14272/000114036125040063/ny20057651x1_424b2.htm) | Nov 3, 2025 | — | Prospectus |
| [POSASR](https://www.sec.gov/Archives/edgar/data/14272/000114036125040010/ny20057651x2_posasr.htm) | Oct 31, 2025 | — |  |
| [144](https://www.sec.gov/Archives/edgar/data/14272/000195917325005660/xsl144X01/primary_doc.xml) | Sep 2, 2025 | — | Notice of proposed sale |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427225000109/a2024thrift11-k.htm) | Jun 6, 2025 | Dec 31, 2024 | FORM 11-K |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427225000108/a2024puertorico11-k.htm) | Jun 6, 2025 | Dec 31, 2024 | FORM 11-K |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427225000107/a2024sips11-k.htm) | Jun 6, 2025 | Dec 31, 2024 | FORM 11-K |
| [25-NSE](https://www.sec.gov/Archives/edgar/data/14272/000087666125000341/xslF25X02/primary_doc.xml) | May 15, 2025 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036125018510/ny20045431x7_sctota.htm) | May 13, 2025 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036125017439/ny20045431x6_sctota.htm) | May 6, 2025 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036125017234/ny20045431x5_sctota.htm) | May 5, 2025 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036125014959/ny20045431x4_sctota.htm) | Apr 23, 2025 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036125014416/ny20045431x3_sctota.htm) | Apr 17, 2025 | — | SC-TO-T/A |
| [SC TO-T](https://www.sec.gov/Archives/edgar/data/14272/000114036125013626/ny20045431x2_sctot.htm) | Apr 14, 2025 | — |  |
| [ARS](https://www.sec.gov/Archives/edgar/data/14272/000114036125010441/ef20046253_ars.pdf) | Mar 26, 2025 | Dec 31, 2024 |  |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/14272/000114036125008624/ny20045431x1_sctoc.htm) | Mar 13, 2025 | — |  |
| [S-3ASR](https://www.sec.gov/Archives/edgar/data/14272/000114036124049473/ny20039851x1_s3asr.htm) | Dec 13, 2024 | — | Short-form registration statement |
| [144](https://www.sec.gov/Archives/edgar/data/14272/000195917324007351/xsl144X01/primary_doc.xml) | Nov 4, 2024 | — | Notice of proposed sale |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427224000104/a2023thrift11-k.htm) | Jun 25, 2024 | Dec 31, 2023 | FORM 11-K |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427224000103/a2023puertorico11-k.htm) | Jun 25, 2024 | Dec 31, 2023 | FORM 11-K |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427224000102/a2023sips11-k.htm) | Jun 25, 2024 | Dec 31, 2023 | FORM 11-K |
| [ARS](https://www.sec.gov/Archives/edgar/data/14272/000114036124016271/ny20016133x4_ars.pdf) | Mar 28, 2024 | Dec 31, 2023 |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036124009146/ny20021323x4_sctota.htm) | Feb 23, 2024 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/14272/000114036124008373/ny20020700x2_424b5.htm) | Feb 16, 2024 | — | Prospectus |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/14272/000114036124008303/filename1.htm) | Feb 16, 2024 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036124008300/ny20021323x2_sctota.htm) | Feb 16, 2024 | — |  |
| [FWP](https://www.sec.gov/Archives/edgar/data/14272/000114036124008105/ny20020700x4_fwp.htm) | Feb 15, 2024 | — |  |
| [424B2](https://www.sec.gov/Archives/edgar/data/14272/000114036124007269/ny20020700x1_424b2.htm) | Feb 13, 2024 | — | Prospectus |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036124006876/ny20021323x1_sctota.htm) | Feb 12, 2024 | — |  |
| [SC TO-T](https://www.sec.gov/Archives/edgar/data/14272/000114036124003759/ny20019237x1_sctot.htm) | Jan 25, 2024 | — |  |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/14272/000114036123059406/ny20017436x1_sctoc.htm) | Dec 26, 2023 | — |  |
| [DFAN14A](https://www.sec.gov/Archives/edgar/data/14272/000114036123059167/ef20017355_dfan14a.htm) | Dec 22, 2023 | — |  |
| [DFAN14A](https://www.sec.gov/Archives/edgar/data/14272/000114036123059165/ef20017313_dfan14a.htm) | Dec 22, 2023 | — |  |
| [424B5](https://www.sec.gov/Archives/edgar/data/14272/000114036123050840/ny20013200x3_424b5.htm) | Nov 1, 2023 | — | Prospectus |
| [FWP](https://www.sec.gov/Archives/edgar/data/14272/000114036123050306/ny20013200x2_fwp.htm) | Oct 30, 2023 | — |  |
| [424B3](https://www.sec.gov/Archives/edgar/data/14272/000114036123050061/ny20013200x1_424b3.htm) | Oct 30, 2023 | — | Prospectus |
| [DFAN14A](https://www.sec.gov/Archives/edgar/data/14272/000114036123047514/ef20012187_dfan14a.htm) | Oct 10, 2023 | — |  |
| [144](https://www.sec.gov/Archives/edgar/data/14272/000195917323003498/xsl144X01/primary_doc.xml) | Aug 24, 2023 | — | Notice of proposed sale |
| [144](https://www.sec.gov/Archives/edgar/data/14272/000195917323002885/xsl144X01/primary_doc.xml) | Aug 3, 2023 | — | Notice of proposed sale |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427223000123/a2022thrift11-k.htm) | Jun 8, 2023 | Dec 31, 2022 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427223000122/a2022puertorico11-k.htm) | Jun 8, 2023 | Dec 31, 2022 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/14272/000001427223000121/a2022sips11-k.htm) | Jun 8, 2023 | Dec 31, 2022 |  |
| [144](https://www.sec.gov/Archives/edgar/data/14272/000195917323000812/xsl144X01/primary_doc.xml) | May 3, 2023 | — | Notice of proposed sale |
| [ARS](https://www.sec.gov/Archives/edgar/data/14272/000114036123013447/ny20006581x3_ars.pdf) | Mar 23, 2023 | Dec 31, 2022 | FORM ARS |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036122029751/brhc10040851_sctota.htm) | Aug 16, 2022 | — | SC TO-TA |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036122028803/brhc10040530_sctota.htm) | Aug 9, 2022 | — | SC TO-TA |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/14272/000114036122026304/brhc10039766_sctota.htm) | Jul 19, 2022 | — |  |

The latest 60 of 118 in EDGAR's recent list.

### What the forms are

**Form 3 — Initial statement of beneficial ownership**

An insider's first statement of holdings in the company's equity securities. Insiders are officers, directors and holders of more than 10 percent of a class of its registered equity securities.

**Form 4 — Statement of changes in beneficial ownership**

An insider's transactions in the company's equity securities, disclosed within two business days of the transaction.

**Form 5 — Annual statement of beneficial ownership**

An insider's annual statement of holdings in the company's equity securities.

**Form 144 — Notice of proposed sale**

In the SEC's Forms Index: notice of proposed sale of securities pursuant to Rule 144.

**Form 10-K — Annual report**

Audited annual financial statements, a discussion of material risk factors, and management's discussion and analysis of the results for the prior fiscal year.

**Form 10-Q — Quarterly report**

Unaudited quarterly financial statements, updates on material risks, and management's discussion and analysis of the results for the prior fiscal quarter.

**Form 8-K — Current report**

Discloses material events or information the company chooses or is required to make public before its next scheduled quarterly or annual report. Each report lists the items it covers.

**Schedule 13D — Schedule 13D beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities; also used to disclose later changes to the holding.

**Schedule 13G — Schedule 13G beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities as a passive investment.

**Form DEF 14A — Definitive proxy statement**

The final proxy statement sent to shareholders for a shareholder meeting: the matters to be voted on, and typically executive and board compensation and who owns more than five percent.

**Form PRE 14A — Preliminary proxy statement**

A preliminary proxy statement subject to review by the SEC staff.

**Form S-8 — Registration statement for employee plans**

In the SEC's Forms Index: registration statement under the Securities Act of 1933 for securities to be offered to employees under certain plans.

**Form S-3 — Short-form registration statement**

An abbreviated registration statement available to certain already-reporting companies to register the offer and sale of securities to the public.

**Form 424B — Prospectus**

A document disclosing information about the company and an offering; it typically makes up a large part of the registration statement.

From the SEC's own descriptions: [SEC, Using EDGAR to Research Investments](https://www.sec.gov/search-filings/edgar-search-assistance/using-edgar-research-investments); [SEC, Forms Index](https://www.sec.gov/submit-filings/forms-index); [SEC, Form 8-K and its items (PDF)](https://www.sec.gov/files/form8-k.pdf).

### Questions and answers

**Where is Bristol-Myers Squibb's latest annual report (10-K)?**

Bristol-Myers Squibb filed its latest Form 10-K with the SEC on February 11, 2026 for the period ended December 31, 2025. The table of annual and quarterly reports on this page links to the document on sec.gov.

**When did Bristol-Myers Squibb file its latest 10-Q?**

On October 29, 2026 for the period ended September 30, 2026. A Form 10-Q holds unaudited quarterly financial statements and management's discussion of the quarter.

**What has Bristol-Myers Squibb reported on Form 8-K recently?**

Its latest 8-K was filed on October 29, 2026 (2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure). In the last twelve months the items it reported most often were: 7.01 Regulation FD Disclosure (5 reports); 2.02 Results of Operations and Financial Condition (4 reports); 5.07 Submission of Matters to a Vote of Security Holders (1 report). An 8-K discloses material events before the next quarterly or annual report.

**How many insider filings (Forms 3, 4 and 5) were there for BMY in the last year?**

63 insider forms in the twelve months to November 18, 2026, the latest a Form 4 filed on November 6, 2026. Officers, directors and holders of more than 10 percent of a class of the company's registered equity securities must disclose their holdings and transactions; a Form 4 is due within two business days of a trade.

**Has anyone reported owning more than 5% of Bristol-Myers Squibb?**

EDGAR lists 3 Schedule 13D or 13G filings about Bristol-Myers Squibb in the last twelve months, the latest on August 7, 2026. These are filed by a party that acquires more than five percent of a class of the company's voting securities; 13G is for passive investors.

### Learn

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Bristol-Myers Squibb (BMY) SEC filings: 10-K, 10-Q and 8-K”, data as of 18 November 2026. https://funkfolio.com/stock/BMY/filings

Underlying data: SEC EDGAR submissions (data.sec.gov).
